CD4 and neoplasm: Given the increased expression of GzmB, IFNγ and TNFα by M002-treated CD4+ T cells, and their tumor reactivity, we next determined if these CD4+ T cells were capable of mediating killing of tumor cells beyond their conventional helper activity.